Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

BMRN BioMarin Pharmaceuticals Inc
$63.23 2.41% +1.49
Notify me if price changes either direction
Interactive Brokers Logotype

Buy BMRN stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 11.9B
Enterprise value 11.0B
Trailing PE 22.98513
Forward PE 11.752899
PEG Ratio -0.17877323333333
Enterprise to EBITDA 13.859
Enterprise to revenue 3.557
Price to book MRQ 1.9610518
Price to sales TTM 3.8391812

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 3.1B
EBITDA 640.5M
Diluted EPS TTM 2.69
Total Cash (MRQ) 1.5B
Current ratio (MRQ) 4.828
Operating Cash Flow (TTM) 914.0M

BMRN trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent BMRN News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.